Cell-Based Botulinum Toxin Assay With Temperature-Tuned Sensitivity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cell-based assays for detecting botulinum toxins lack sensitivity, which is inadequate for detecting low concentrations of botulinum neurotoxins, particularly in the context of potential bioterrorism threats and food poisoning, as they often require expensive and regulated animal testing methods.
Innovation Solution
The use of transfected cells expressing hybrid proteins with a reporter-containing portion and a cleavage site that is specifically cleaved by botulinum toxins, combined with optimized temperature and media conditions such as elevated temperatures (38° C. to 41° C.) and reduced sodium concentrations, to enhance the sensitivity of the detection process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional cell-based assays are used for botulinum toxin detection, then the method avoids animal testing and reduces cost, but the sensitivity is insufficient for detecting low concentrations of toxin
Solution Approach 1:
The patent applies parameter changes by optimizing culture conditions including temperature (37°C during differentiation, then shifted to 20-37°C during assay), media composition (NBM with B27 supplement, glucose concentration 10-25 mM), and cell density (50-200 cells per well) to enhance the sensitivity of the cell-based assay for detecting botulinum toxin at low concentrations while maintaining assay reliability
2Measurement precision
If mouse toxicity assays are used for botulinum toxin detection, then high sensitivity is achieved, but the method is expensive and subject to animal testing regulations
Solution Approach 1:
The patent uses a cell-based system that copies the essential biological functions needed for toxin detection (receptor-mediated endocytosis and proteolytic cleavage of substrate proteins) without requiring whole animal systems. The assay employs cells expressing SNARE proteins and fluorescent reporters that replicate the toxic mechanism in a simplified, regulated-compliant format
Solution Approach 2:
The patent replaces the mechanical/biological complexity of whole animal toxicity assays with a cell-based biochemical system using fluorescent detection. The assay substitutes animal-based physiological responses with cell-based fluorescent signal changes that are easier to measure and regulate
3Device complexity
If cell-based assays with conventional conditions are used, then the assay is simpler and cheaper, but the sensitivity EC50 value remains in the ≧10 pM range which is insufficient for many applications
Solution Approach 1:
The patent systematically optimizes multiple parameters including temperature profiles (differentiation at 37°C followed by assay at 20-37°C), media composition (NBM with B27, glucose 10-25 mM), cell density (50-200 cells per well), and incubation times to achieve enhanced sensitivity while keeping the assay relatively simple and cost-effective
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach significantly increases the sensitivity of cell-based assays for botulinum toxins, allowing for detection of low concentrations and improving the reliability of assays without the need for animal testing, thereby enhancing the detection capabilities for botulinum neurotoxins.
Implementation Method 1
the light chain is translocated from the endosomal vesicle lumen into the cytosol, and acts as a zinc-dependent protease to cleave proteins that mediate vesicle-target membrane fusion
Implementation Method 2
The heavy chain mediates toxin entry into a target cell through receptor-mediated endocytosis
Implementation Method 3
utilizing Förster resonance energy transfer (FRET) and in other instances utilizing non-FRET methods to provide fluorescence useful for the detection and characterization of BoNTs
Data Source
AI summary
Methods and compositions are provided where a transfected cell that produces a hybrid protein with a reporter-containing portion and a botulinum toxin cleavage site is contacted with a botulinum toxin at elevated temperatures and/or in media having a reduced sodium concentration. Kits that include such media and a botulinum toxin are also described.